CEO Jeff Comer Shares Tips for Effective Business Management
CAVE CREEK, AZ / ACCESSWIRE / December 9, 2020 / Dr. Jeff Comer, a successful leader in the Alaska healthcare...
Month: December 2020
Adial Pharmaceuticals CEO Weighs in on the Alcohol Pandemic and Drunk Driving Over the Holidays; FOX31 Denver’s Shaul Turner Interviews Bill Stilley
CHARLOTTESVILLE, VA / ACCESSWIRE / December 9, 2020 / Adial Pharmaceuticals, Inc. (NASDAQ:ADIL; ADILW), a clinical-stage biopharmaceutical company focused on...
Nationwide Medication Savings Leader Prescription Hope Maintains Full Operational Capacity During COVID-19
STUART, FL / ACCESSWIRE / December 9, 2020 / Prescription Hope, one of the largest patient assistance program administrators in...
Leafbuyer Technologies Inc. Announces Positive Cash Flow
Company Achieves Rare Milestone in Cannabis Industry DENVER, CO / ACCESSWIRE / December 9, 2020 / Leafbuyer Technologies, Inc. ("Leafbuyer"...
9 Meters Biopharma, Inc. Receives Orphan Drug Designation for NM-003, a Proprietary Long-Acting GLP-2, for Prevention of Acute Graft Versus Host Disease (aGvHD)
aGvHD among potential indications being considered for next stage of development Candidate to move to IND-enabling studies in 2021 RALEIGH,...
Chemesis International Inc. Announces Partnership with the RESET Group
The Companies will work together to bring Chemesis' AI retail solution to Portland, Oregon VANCOUVER, BC / ACCESSWIRE / December...
Grapefruit USA, Inc. Announces Execution of New License Agreement with Zylö Therapeutics Inc. Expanding Grapefruit’s Patented Hourglass Product line to include Hemp-Derived CBD Topical Delivery Creams For Nationwide Distribution
Powered by Zylö's patented Xerogel Silica Gel ("Z-Pod™") delivery system, Grapefruit's Patented Hourglass™ THC + Cannabinoid Topical Cream is the...
CohBar Confirms Efficacy of Novel Apelin Agonists in Acute Respiratory Distress Syndrome (ARDS) Model
MENLO PARK, Calif., Dec. 09, 2020 (GLOBE NEWSWIRE) -- CohBar, Inc. (NASDAQ: CWBR), a clinical stage biotechnology company developing mitochondria...
Arcutis Highlights Advanced Pipeline & Unique Immuno-Dermatology Drug Development Capabilities at Virtual Investor Day on December 9, 2020
Broad and deep portfolio of highly differentiated product candidates aligned with needs of patients and doctorsRobust pipeline includes 4 development...
Telo Genomics Presents at ASH 2020 The Results of Hodgkin’s Lymphoma Clinical Study
TORONTO, Dec. 09, 2020 (GLOBE NEWSWIRE) -- Telo Genomics Corp. (TSX-V: TELO) (the “Company” or “TELO”) is pleased to announce...
Amunix Presents Preclinical Data on AMX-818, a Protease-Activated HER2-Targeted T Cell Engager Prodrug, at SABCS 2020
– Data demonstrate potential of Amunix’s XPAT (XTENylated Protease-Activated T cell engager) platform to mitigate on-target, off-tumor toxicity that has...
Novartis Kisqali® demonstrates nearly five years median overall survival in metastatic breast cancer
MONALEESA-7 median overall survival (OS) results reinforce Kisqali as the CDK4/6 inhibitor with unrivaled OS evidence1Kisqali plus endocrine therapy had...
Sorrento Receives US FDA Clearance to Proceed With Phase 1 Clinical Trials for STI-2020 (COVI-AMG) in Healthy Volunteers and in Newly Diagnosed COVID-19 Patients
FDA has granted clearance for the commencement of Phase 1 clinical trials of STI-2020 (COVI-AMGTM) in healthy volunteers and COVID-19...
BriaCell Presents Clinical Data at the 2020 San Antonio Breast Cancer Symposium®
Disease control and survival data is presented from the clinical trials of Bria-IMT™ alone or in combination with immune checkpoint...
Evelo Biosciences Announces New Clinical Candidate in Oncology and Presents Additional Interim Data from Phase 1/2 Clinical Trial of EDP1503 in Patients with Triple-Negative Breast Cancer
–EDP1908 announced as clinical candidate in oncology after showing superior preclinical activity over EDP1503––Interim clinical data for EDP1503 suggest potential...
Pure Extracts Signs LOI with The Nutraceutical Medicine Company – Owner of the PURICA™ Brand of Wellness Products
VANCOUVER, British Columbia, Dec. 09, 2020 (GLOBE NEWSWIRE) -- Pure Extracts Technologies Corp. (CSE: PULL) (XFRA: A2QJAJ) (“Pure Extracts” or...
Y-mAbs Announces Update on DANYELZA® (naxitamab-gqgk) at ESMO
NEW YORK, Dec. 09, 2020 (GLOBE NEWSWIRE) -- Y-mAbs Therapeutics, Inc. (the “Company” or “Y-mAbs”) (Nasdaq: YMAB) a commercial-stage biopharmaceutical...
Ellume’s COVID-19 Home Test shows 96% accuracy in multi-site US clinical study
The Ellume COVID-19 Home Test App The Ellume COVID-19 Home Test connects directly to users’ smartphone, providing for step-by-step instructions...
SEngine Precision Medicine Presents Data Summarizing Predictive Value of PARIS® Test in Breast Cancer Patients at 2020 San Antonio Breast Cancer Symposium
SEATTLE, Dec. 09, 2020 (GLOBE NEWSWIRE) -- SEngine Precision Medicine, a precision oncology company revolutionizing cancer therapies by pre-testing drugs...
PDS Biotechnology Appoints Seth Van Voorhees as Chief Financial Officer
FLORHAM PARK, N.J., Dec. 09, 2020 (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation (Nasdaq: PDSB), a clinical-stage immunotherapy company developing novel...